-
-
-
-
-
-
-
Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President
-
-
-
-
-
-
-
Ultragenyx Reports Preliminary 2019 Revenue and Provides 2020 Crysvita Revenue Guidance
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) to Submit NDA to FDA for UX007 for Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) Says FDA Accepts Burosumab BLA; Sets 04/17/18 PDUFA Date
-
-
15,674 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

